These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29881683)

  • 1. Inhalation treatment of primary lung cancer using liposomal curcumin dry powder inhalers.
    Zhang T; Chen Y; Ge Y; Hu Y; Li M; Jin Y
    Acta Pharm Sin B; 2018 May; 8(3):440-448. PubMed ID: 29881683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal andrographolide dry powder inhalers for treatment of bacterial pneumonia via anti-inflammatory pathway.
    Li M; Zhang T; Zhu L; Wang R; Jin Y
    Int J Pharm; 2017 Aug; 528(1-2):163-171. PubMed ID: 28583330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary delivery of liposomal dry powder inhaler formulation for effective treatment of idiopathic pulmonary fibrosis.
    Chennakesavulu S; Mishra A; Sudheer A; Sowmya C; Suryaprakash Reddy C; Bhargav E
    Asian J Pharm Sci; 2018 Jan; 13(1):91-100. PubMed ID: 32104382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
    Kolanjiyil AV; Kleinstreuer C; Sadikot RT
    Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and Characterization of Spray-Dried Proliposomes for the Pulmonary Delivery of Curcumin.
    Adel IM; ElMeligy MF; Abdelrahim MEA; Maged A; Abdelkhalek AA; Abdelmoteleb AMM; Elkasabgy NA
    Int J Nanomedicine; 2021; 16():2667-2687. PubMed ID: 33854314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of Curcumin Solid Lipid Nanoparticles Loaded with Flower-Shaped Lactose for Lung Inhalation and Preliminary Evaluation of Cytotoxicity In Vitro.
    Li N; Li X; Cheng P; Yang P; Shi P; Kong L; Liu H
    Evid Based Complement Alternat Med; 2021; 2021():4828169. PubMed ID: 34745284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cepharanthine Dry Powder Inhaler for the Treatment of Acute Lung Injury.
    Liang D; Wang W; Chen G; Li J; Dou G; Gan H; Han P; Du L; Gu R
    Molecules; 2023 May; 28(11):. PubMed ID: 37298919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary disposition of budesonide from liposomal dry powder inhaler.
    Joshi M; Misra AN
    Methods Find Exp Clin Pharmacol; 2001 Dec; 23(10):531-6. PubMed ID: 11957743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Evaluation of Paclitaxel and Curcumin Dry Powder for Inhalation Lung Cancer Treatment.
    Lee WH; Loo CY; Traini D; Young PM
    Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33375181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preparation of liposomal artesunate dry powder inhalers and the effect on the acute lung injury of rats].
    Hu YZ; Li M; Zhang TT; Jin YG
    Yao Xue Xue Bao; 2016 Dec; 51(12):1906-12. PubMed ID: 29923696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal dry powders as aerosols for pulmonary delivery of proteins.
    Lu D; Hickey AJ
    AAPS PharmSciTech; 2005 Dec; 6(4):E641-8. PubMed ID: 16408866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dry-Powder Inhaler Formulation of Rifampicin: An Improved Targeted Delivery System for Alveolar Tuberculosis.
    Rawal T; Kremer L; Halloum I; Butani S
    J Aerosol Med Pulm Drug Deliv; 2017 Dec; 30(6):388-398. PubMed ID: 28510480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential and constraints for the application of CFD combined with Lagrangian particle tracking to dry powder inhalers.
    Sommerfeld M; Cui Y; Schmalfuß S
    Eur J Pharm Sci; 2019 Feb; 128():299-324. PubMed ID: 30553814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhalable oridonin-loaded poly(lactic-
    Zhu L; Li M; Liu X; Du L; Jin Y
    Acta Pharm Sin B; 2017 Jan; 7(1):80-90. PubMed ID: 28119812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical relevance of dry powder inhaler performance for drug delivery.
    Demoly P; Hagedoorn P; de Boer AH; Frijlink HW
    Respir Med; 2014 Aug; 108(8):1195-203. PubMed ID: 24929253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redispersible liposomal-N-acetylcysteine powder for pulmonary administration: development, in vitro characterization and antioxidant activity.
    Ourique AF; Chaves Pdos S; Souto GD; Pohlmann AR; Guterres SS; Beck RC
    Eur J Pharm Sci; 2014 Dec; 65():174-82. PubMed ID: 25263567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in liposomal dry powder formulations: preparation and evaluation.
    Misra A; Jinturkar K; Patel D; Lalani J; Chougule M
    Expert Opin Drug Deliv; 2009 Jan; 6(1):71-89. PubMed ID: 19236209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of inhalable microparticle of flower of Lonicera japonica in a mouse model of COPD.
    Park YC; Jin M; Kim SH; Kim MH; Namgung U; Yeo Y
    J Ethnopharmacol; 2014; 151(1):123-30. PubMed ID: 24211495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano-liposomal dry powder inhaler of Amiloride Hydrochloride.
    Chougule MB; Padhi BK; Misra A
    J Nanosci Nanotechnol; 2006; 6(9-10):3001-9. PubMed ID: 17048511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of liposomal salbutamol sulfate dry powder inhaler formulation.
    Huang WH; Yang ZJ; Wu H; Wong YF; Zhao ZZ; Liu L
    Biol Pharm Bull; 2010; 33(3):512-7. PubMed ID: 20190418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.